DBV Technologies S.A. (EPA:DBV)
France · Delayed Price · Currency is EUR 3.080
+0.055 (1.82%)
Jan 12, 2026, 11:44 AM CET
DBV Technologies Market Cap
DBV Technologies has a market cap or net worth of €606.87 million as of January 12, 2026. Its market cap has increased by 839.33% in one year.
Market Cap
606.87M
Enterprise Value
553.90M
Revenue
4.69M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.08
Market Cap Chart
Since March 29, 2012, DBV Technologies's market cap has increased from 79.23M to 606.87M, an increase of 665.98%. That is a compound annual growth rate of 15.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 606.87M | -10.50% |
| Dec 31, 2025 | 678.09M | 949.56% |
| Dec 31, 2024 | 64.61M | -63.70% |
| Dec 29, 2023 | 177.98M | -39.80% |
| Dec 30, 2022 | 295.62M | 75.76% |
| Dec 31, 2021 | 168.19M | -29.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 128.15B |
| Sanofi | 102.75B |
| Sartorius Stedim Biotech | 20.85B |
| bioMérieux | 13.33B |
| Eurofins Scientific SE | 12.24B |
| Ipsen | 10.46B |
| ABIVAX Société Anonyme | 7.71B |
| Virbac | 3.05B |